Pioneering the future of medicine
Early phase trials are becoming more complex but have traditionally provided limited insight early on, delaying key development decisions. This paper explores how integrating advanced procedures, digital tools, biomarkers and AI can generate richer, earlier data on safety and efficacy. By using hybrid trial models and continuous data capture, sponsors can reduce uncertainty, accelerate decision making and design studies that are more efficient while also reducing burden on participants.
Offered Free by: Trialmed
See All Resources from: Trialmed
